Covered recipient · General Payments record
ROBERT J REICHLING
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,242.23
- Reported across 285 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.64 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $50.61 | 3 |
| PFIZER INC. | $38.77 | 2 |
| Tandem Diabetes Care, Inc. | $27.79 | 1 |
| BAXTER HEALTHCARE | $25.10 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $22.75 | 1 |
| GlaxoSmithKline, LLC. | $18.53 | 1 |
| Insulet Corporation | $17.19 | 1 |
| ABBVIE INC. | $16.12 | 1 |
| Novo Nordisk AS | $15.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.12 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105934568 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $22.75 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147002730 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.79 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104724427 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.51 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104606516 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.31 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104368495 | CMS |
| Baxter Healthcare | $25.10 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120646636 | CMS |
| GlaxoSmithKline, LLC. | $18.53 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115862950 | CMS |
| Insulet Corporation | $17.19 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116823586 | CMS |
| Novo Nordisk Inc | $15.78 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096922652 | CMS |
| PFIZER INC. | $22.23 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131348680 | CMS |
| PFIZER INC. | $16.54 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130881468 | CMS |
| Tandem Diabetes Care, Inc. | $27.79 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138739413 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.